Home › GLP-1 Reviews › MEDVi

MEDVi Review: Is the $179 GLP-1 Program Worth It in 2026?

MEDVi offers compounded semaglutide and tirzepatide through licensed telehealth providers at some of the lowest cash-pay prices in the category. We dug into the pricing, the certifications, and the complaints. Here's the honest breakdown.

By The HealthCompare Editorial Team • Updated May 21, 2026 • 10 min read

MEDVi

Cash-pay GLP-1 telehealth · compounded & branded options

4.0

out of 5

★★★★☆

Pricing

4.6

Access

4.5

Support

3.2

Billing clarity

3.0

$179 first month · no insurance required

Check MEDVi pricing

What we liked

Low entry price — $179 for the first month, including consultation, medication and shipping
No insurance and no long-term contract; month-to-month
LegitScript certified, with licensed providers via OpenLoop
Large, mostly positive review base (4.4–4.5 on Trustpilot)
Multiple options: compounded semaglutide, tirzepatide, and branded paths

What to watch out for

Refunds are restrictive — policy states no refund on standard cancellation
Money-back guarantee requires 5 months of adherence, minus a 25% fee
Recurring billing complaints, including charges after cancellation

Our verdict at a glance

MEDVi is a legitimate, LegitScript-certified telehealth platform that has made GLP-1 weight-loss medication far more affordable for cash-paying patients. Branded drugs like Wegovy and Ozempic often run $1,300–$1,500 a month without insurance, while MEDVi's compounded semaglutide starts at $179 for the first month. That price gap is the core of its appeal, and it's a real one.

The catch is on the back end. Across thousands of reviews, the most consistent complaints aren't about the medication or the providers — they're about billing and refunds. The money-back guarantee reportedly shifted from three months to five, standard cancellations aren't refunded, and several customers report being charged after they thought they'd cancelled. If you go in understanding those terms, MEDVi is one of the most accessible options available. If you expect easy refunds, you may be frustrated.

Bottom line: A strong pick for cash-pay patients who want low-cost GLP-1 access and who read the billing terms carefully before enrolling. Confirm current pricing and the refund policy directly on MEDVi's site before you sign up.

MEDVi pricing in 2026

MEDVi uses a flat first-month promotional price that includes your provider consultation, the medication, and shipping, then moves to standard monthly pricing. The figures below reflect the most recent publicly reported pricing as of this update — always verify on MEDVi's own site, as compounded pricing in this category shifts often.

MEDVi GLP-1 program product — MEDVi's compounded GLP-1 program. Check current pricing on the official site.

Program	First month	Ongoing / month
Compounded semaglutide (injection)	$179	$299
Compounded semaglutide (tablets)	$249	$369
Compounded tirzepatide	$279	$399
Branded Ozempic (no insurance)	—	~$1,999

There's no membership fee on the compounded path and no insurance requirement. Branded paths reportedly use a separate membership-plus-medication model.

How MEDVi works

The process is built around three steps. First, you complete an online health questionnaire covering your medical history, current medications, and weight-loss goals. Next, a licensed provider through MEDVi's clinical partner network reviews your submission — usually within about 24 hours — and makes an independent prescribing decision; MEDVi states it does not employ the physicians or influence those decisions. Finally, if approved, your medication ships directly to your door. Lab work isn't always required, though it may be requested for certain conditions.

Reputation & trust

MEDVi is a real, sizeable operation — its 2025 revenue was independently verified at around $401 million by the New York Times, and it reports having served more than 100,000 patients. It holds LegitScript certification and works with licensed U.S. providers across most states.

Customer sentiment is genuinely split by platform. On Trustpilot, MEDVi averages roughly 4.4–4.5 stars across more than 11,000 reviews; on ConsumerAffairs it sits closer to 3.6 across about 1,600 reviews. The positive reviews cite appetite suppression, real weight loss, fast shipping, and easy enrollment. The negative ones cluster heavily around billing and refunds.

Worth knowing: In 2026 the FDA issued a warning letter tied to marketing at a domain MEDVi attributes to an affiliate, and its clinical infrastructure partner reported a data breach. MEDVi's founder publicly responded committing to stop AI-generated advertising. Compounded GLP-1 medications are not FDA-approved. None of this means MEDVi is illegitimate, but these are real factors to weigh.

Who it's for

A good fit if you…

Are paying cash, want the lowest realistic entry price for GLP-1 treatment, are comfortable with compounded medication, and will read the cancellation and refund terms before enrolling.

Maybe look elsewhere if you…

Need a simple, no-questions refund policy, want only FDA-approved branded medication at a low price, or aren't comfortable with the recurring-billing complaints documented by some customers.

How we reviewed MEDVi

We reviewed MEDVi's publicly listed pricing, certifications, and program structure, and analyzed customer feedback across Trustpilot, ConsumerAffairs, and BBB, alongside reporting on its regulatory standing. Our scores are editorially independent — our affiliate relationship never changes a rating. Pricing and policy details change frequently in this category, so we note our last update date and recommend confirming specifics on MEDVi's official site.

Thinking about MEDVi?

Check current pricing, available medications, and the refund terms in your state before enrolling.

Visit MEDVi We may earn a commission. This doesn't affect our rating or the price you pay.

MEDVi: Affordable, Doctor-Led GLP-1 Weight Loss To Your Door

Healthcare designed around your real life, not a waiting room.

What Is MEDVi?

MEDVi is a U.S.-based telehealth platform that makes medically supervised GLP-1 weight loss affordable and convenient for adults who want real clinical support without the traditional barriers of insurance, pharmacy lines, and clinic visits.

The National Institutes of Health reports that nearly forty percent of American adults now manage metabolic health through digital clinics because traditional programs often require rigid schedules and expensive facility memberships. MEDVi matches you with board-certified providers through the OpenLoop Health clinician network. These providers review your medical history, prescribe clinically studied GLP-1 medications when appropriate, and ship them directly to your address through licensed U.S. compounding pharmacies.

You skip the parking fees, the crowded waiting rooms, and the outdated diet sheets that collect dust on kitchen counters. Rather than demanding impossible lifestyle overhauls, MEDVi delivers a clear treatment roadmap that fits your actual calendar. Your clinician monitors your progress through secure messaging and check-ins, so your MEDVi prescription stays aligned with how you actually live.

How MEDVi Sends Personalized Care Directly to You?

Step 1: Confidential Online Evaluation

You answer straightforward questions about your weight goals, current habits, medical history, and any medications you take. Secure encryption protects every detail during transmission, so your health information stays completely private. This digital intake replaces the tedious paperwork that usually wastes half an hour at traditional clinics. You also upload a photo ID to verify your identity, which keeps the MEDVi platform compliant with telehealth regulations across the states it serves.

Step 2: Independent Clinician Review

A licensed, board-certified provider through the OpenLoop Health network reviews your responses, typically within 24 to 48 hours. They evaluate medication interactions, screen for contraindications, confirm appropriate starting doses, and schedule a brief video consultation when your profile requires additional discussion. Real medical professionals guide every prescribing decision rather than automated algorithms — and MEDVi itself does not influence those clinical determinations.

Step 3: Cold-Pack Delivery to Your Door

Once your MEDVi clinician approves your treatment plan, the prescription is sent to a partner U.S. compounding pharmacy. Your order is prepared, ships in temperature-controlled packaging with ice packs, and you can track it through your MEDVi dashboard until it arrives. Standard fulfillment typically takes a few business days, with expedited options available at checkout for urgent needs.

Why Patients Choose MEDVi

Transparent Pricing

Clear, upfront monthly rates with no hidden membership fees and no surprise charges. MEDVi semaglutide starts at $179 for the first month, with locked refill pricing at $299 that does not increase as your dose escalates. You budget accurately without unpredictable billing statements.

Clinical Oversight

Board-certified providers through the OpenLoop Health network monitor every step of your MEDVi treatment. Medical safety stays prioritized over quick sales tactics, and your prescribing clinician retains full independent judgment over dose adjustments and plan changes.

Discreet Packaging

Plain, unmarked shipping boxes with no external branding. Your neighbors, building staff, and delivery drivers never see your prescription details. Temperature-controlled mailers keep your MEDVi medication cold during transit without advertising what is inside.

Flexible Refills

Automatic shipment schedules that match your dosage timeline. You never run out of medication during busy work weeks, vacations, or holiday seasons. Skip a cycle, pause your plan, or adjust your delivery date directly from your MEDVi dashboard.

FDA Approved Options

For patients who prefer FDA-approved branded medications, MEDVi offers access to Wegovy and Ozempic through partner pharmacies at standard market pricing alongside its compounded semaglutide and tirzepatide programs. You and your clinician choose the path that fits your goals and budget.

Secure Messaging

Direct communication with your prescribing MEDVi clinician through encrypted messaging. Ask questions about side effects, dose adjustments, or progress without booking an appointment. Quick clinical answers replace unnecessary in-person visits and phone tag.

MEDVi Review: Real Stories From Real Patients

Everyday MEDVi users share how a structured digital program simplifies medically supervised weight loss. Marcus from Colorado explained that he finally maintained his prescribed regimen because the automatic refill system matched his travel schedule. He noted that skipping the monthly clinic visit saved him nearly three hours every month, and that the locked $299 refill rate let him budget without anxiety.

Elena in Michigan switched to MEDVi after her local weight-loss clinic raised program fees, and she now pays roughly twenty-five percent less for the same compounded semaglutide. Lauren in Texas, a longer-term MEDVi patient, reports a steady 32-pound loss over five months alongside her clinician-guided diet adjustments. These MEDVi review accounts reflect a broader shift toward virtual GLP-1 management.

Research published by the Centers for Disease Control and Prevention confirms that patient adherence improves noticeably when treatment plans remove administrative friction and focus on consistent medication access. With MEDVi, you receive the same clinical quality that traditional weight-loss clinics provide — without the waiting-room magazines from 2014.

MEDVi Pricing Plans

Starter Program — From $179 First Month

Compounded semaglutide injections at the lowest entry price in the MEDVi catalog. Covers your physician evaluation, personalized treatment plan, first month of medication, and shipping. Ideal for first-time GLP-1 patients who want to see how their body responds before committing.

Routine Maintenance — $299 Per Month, Locked

Discounted refill pricing on compounded semaglutide injections with priority clinician support. MEDVi advertises this rate as locked across dose escalation, which is a meaningful cost advantage for patients titrating up to maintenance doses. Includes unlimited messaging with your prescribing clinician.

Complete Bundle — Tirzepatide and Tablet Options

Reduced pricing for patients who need broader treatment support. Compounded tirzepatide injections start at $349 for the first month, semaglutide tablets at $249, and tirzepatide tablets at $279. Patients aged 65 and older qualify for an additional $50 per month senior discount across MEDVi GLP-1 plans.

MEDVi Satisfaction and Refund Policy

MEDVi stands behind every order that leaves its partner pharmacies. If your shipment arrives damaged or contains the incorrect medication, MEDVi replaces it at no extra cost.

Your prescribing clinician also reviews your initial intake, and if GLP-1 treatment does not match your health profile during the medical evaluation, you receive a full refund before any medication is dispensed. MEDVi additionally advertises a weight-loss money-back guarantee for patients who follow the program for the required treatment window without achieving meaningful results — subject to specific eligibility criteria and refund terms detailed in the MEDVi terms of service.

To request resolution, you contact MEDVi support through your dashboard, submit your order number, and the team processes most requests within a standard business window. Healthcare purchases should carry clear protections, and MEDVi builds its policy to match that standard. Always read the full guarantee language and cancellation procedure on the official MEDVi site before enrolling.

Frequently Asked Questions

Are MEDVi medications safe and legitimate?

Yes. MEDVi is a LegitScript-certified telehealth platform that connects patients with licensed, board-certified providers through the OpenLoop Health clinician network. Every prescription is dispensed by a licensed U.S. compounding pharmacy operating in an FDA-regulated facility. MEDVi primarily prescribes compounded versions of semaglutide and tirzepatide, which contain the same active ingredients as FDA-approved brands like Wegovy, Ozempic, Mounjaro, and Zepbound. Note that compounded medications themselves are not individually FDA-approved as finished products. For patients who prefer FDA-approved options, MEDVi also offers brand-name Wegovy and Ozempic through partner pharmacies.

How fast does MEDVi shipping arrive?

Standard processing takes one to two business days after your MEDVi clinician approves the order. You can select expedited shipping at checkout for urgent needs. Temperature-sensitive GLP-1 medications ship in insulated mailers with ice packs that meet United States Pharmacopeia storage guidelines. Most carriers deliver within a few days unless severe weather disrupts regional routes.

Does MEDVi accept insurance?

No. MEDVi is a strictly cash-pay telehealth service. There are no insurance pre-authorizations, no copays, and no coverage gatekeeping — you pay one transparent monthly rate that includes the medication, the clinician, the shipping, and the ongoing support. Many MEDVi patients pay with HSA or FSA cards. For patients without insurance, the published MEDVi cash rate frequently undercuts traditional pharmacy pricing on brand-name GLP-1 medications by a wide margin.

References

Wilding JPH, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine. 2021.
Jastreboff AM, et al. Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1). New England Journal of Medicine. 2022.
U.S. Food and Drug Administration. Drug Approval Package: Wegovy (semaglutide).
U.S. Food and Drug Administration. Drug Approval Package: Zepbound (tirzepatide).
U.S. Food and Drug Administration. Compounding and the FDA: Questions and Answers.
National Institute of Diabetes and Digestive and Kidney Diseases. Prescription Medications to Treat Overweight and Obesity.
Centers for Disease Control and Prevention. Adult Obesity Facts.

FDA Disclaimer and Important Safety Information

These statements have not been evaluated by the Food and Drug Administration. The information presented on this page is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.

MEDVi is a telehealth platform that connects patients with independent, licensed healthcare providers through the OpenLoop Health clinician network. MEDVi is not a pharmacy and does not manufacture, dispense, or sell medications directly. MEDVi does not employ the prescribing clinicians and does not influence their clinical determinations — all prescribing decisions rest with the treating provider based on the medical information provided during the patient intake.

About Compounded Medications: MEDVi primarily prescribes compounded versions of semaglutide and tirzepatide, prepared by licensed U.S. compounding pharmacies operating in FDA-regulated facilities. Compounded medications use FDA-approved active pharmaceutical ingredients, but the finished compounded products are not individually reviewed or approved by the FDA for safety, efficacy, or quality. The FDA generally advises that compounded drugs should be used only when a patient’s medical needs cannot be met by an FDA-approved drug or during recognized shortages. Potency, purity, and stability may vary between compounded formulations, and compounded GLP-1 products are not interchangeable with FDA-approved versions. Availability of compounded GLP-1 medications may change depending on FDA shortage determinations and applicable state laws.

Prescription Medication Notice: The GLP-1 medications prescribed through MEDVi (including semaglutide and tirzepatide) are prescription-only drugs. They should be used only under the supervision of a licensed healthcare provider. Do not start, stop, or change your dose without consulting your prescribing clinician.

Potential Side Effects: Common side effects of GLP-1 receptor agonist medications may include nausea, vomiting, diarrhea, constipation, abdominal pain, headache, fatigue, and injection site reactions. Serious side effects — though rare — may include pancreatitis, gallbladder problems, kidney issues, and severe allergic reactions. GLP-1 medications carry a boxed warning regarding the risk of thyroid C-cell tumors observed in rodent studies. These medications should not be used by individuals with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).

Not Suitable For Everyone: MEDVi medications are not appropriate for pregnant or breastfeeding women, individuals under 18 years of age, or patients with certain medical conditions. Always disclose your complete medical history, current medications, and known allergies during your online assessment.

Brand Name Trademarks: Ozempic®, Wegovy®, Mounjaro®, and Zepbound® are registered trademarks of their respective owners (Novo Nordisk and Eli Lilly). MEDVi is not affiliated with, endorsed by, or sponsored by these trademark holders. References to these brand names are for educational and comparative purposes only.

Individual Results Vary: Weight loss results vary based on adherence, dose, individual metabolism, diet, physical activity, and other lifestyle factors. Patient testimonials presented reflect individual experiences and are not a guarantee of results. Self-reported MEDVi patient outcomes do not represent a randomized clinical trial.

Money-Back Guarantee Terms: MEDVi’s money-back guarantee is subject to specific eligibility criteria, including program adherence requirements and a refund window. Refund amounts may exclude consultation fees. Always review the full guarantee language on the official MEDVi site before enrolling.

Consult Your Healthcare Provider: The content on this page is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or treatment.

By using MEDVi, you acknowledge that you have read, understood, and agreed to the full Terms of Service, Privacy Policy, and Telehealth Consent available on the official MEDVi website.